Using the light-induced retinal degeneration model, an established mouse model to study key aspects of dry AMD [26], we show that genetic deficiency and pharmacological inhibition of galectin-3 both can diminish microglia reactivity and delay light-induced retinal degeneration. This evidence concerns the gene LGALS3 and retinal degeneration.